Moneycontrol
HomeNewsTrendsHealthEven mild COVID-19 infection can harm heart health, study finds
Trending Topics

Even mild COVID-19 infection can harm heart health, study finds

Researchers found that in individuals diagnosed with mild COVID-19, artery and central cardiovascular function were affected by the disease two to three months after infection.

April 28, 2023 / 20:55 IST
Story continues below Advertisement

Representative image

Even mild cases of COVID-19 can have long-term harmful impacts on cardiovascular health, a study has warned.

The study, published in the Journal of Clinical Medicine, is the first to compare pre and post-COVID-infection levels of arterial stiffness; a marker associated with the ageing and function of our arteries.

Story continues below Advertisement

Researchers found that in individuals diagnosed with mild COVID-19, artery and central cardiovascular function were affected by the disease two to three months after infection.

Side effects include stiffer and more dysfunctional arteries that could lead to cardiovascular disease development, they said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show